BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22078784)

  • 1. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis.
    Friedler S; Koc O; Gidoni Y; Raziel A; Ron-El R
    Fertil Steril; 2012 Jan; 97(1):125-33. PubMed ID: 22078784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
    Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation.
    Almog B; Azem F; Gordon D; Pauzner D; Amit A; Barkan G; Levin I
    Fertil Steril; 2012 Oct; 98(4):957-60. PubMed ID: 22763097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.
    Cakmak H; Katz A; Cedars MI; Rosen MP
    Fertil Steril; 2013 Dec; 100(6):1673-80. PubMed ID: 23987516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
    Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
    Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian stimulation for fertility preservation in patients with cancer.
    Quintero RB; Helmer A; Huang JQ; Westphal LM
    Fertil Steril; 2010 Feb; 93(3):865-8. PubMed ID: 19013563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of malignancy on response to ovarian stimulation for fertility preservation: a meta-analysis.
    Turan V; Quinn MM; Dayioglu N; Rosen MP; Oktay K
    Fertil Steril; 2018 Dec; 110(7):1347-1355. PubMed ID: 30503134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
    Alvarez RM; Ramanathan P
    Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation.
    Zhu X; Ye H; Fu Y
    Fertil Steril; 2017 Sep; 108(3):505-512.e2. PubMed ID: 28697910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female fertility preservation: Impact of cancer on ovarian function and oocyte quality.
    Fabiani C; Ferrante MG; Meneghini C; Licata E; Paciotti G; Gallo M; Schiavi M; Spina V; Guarino A; Caserta D; Rago R
    Int J Gynaecol Obstet; 2022 Jan; 156(1):166-171. PubMed ID: 33837528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles.
    Shapira M; Raanani H; Feldman B; Srebnik N; Dereck-Haim S; Manela D; Brenghausen M; Geva-Lerner L; Friedman E; Levi-Lahad E; Goldberg D; Perri T; Eldar-Geva T; Meirow D
    Fertil Steril; 2015 Nov; 104(5):1162-7. PubMed ID: 26335130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of in vitro fertilization/intracytoplasmic sperm injection after laparoscopic cystectomy for endometriomas.
    Esinler I; Bozdag G; Aybar F; Bayar U; Yarali H
    Fertil Steril; 2006 Jun; 85(6):1730-5. PubMed ID: 16690058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
    Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z
    Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled ovarian hyperstimulation for poor ovarian responders undergoing in vitro fertilisation/intracytoplasmic sperm injection: a protocol for systematic review and Bayesian network meta-analysis.
    Yang H; Zheng C; Zheng Q; Xu H; Li X; Hao M; Fang Y
    BMJ Open; 2021 Feb; 11(2):e039122. PubMed ID: 33622939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
    Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
    Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection? Results from a prospective, comparative study.
    Sigala J; Sifer C; Dewailly D; Robin G; Bruyneel A; Ramdane N; Lefebvre-Khalil V; Mitchell V; Decanter C
    Fertil Steril; 2015 Jan; 103(1):112-8. PubMed ID: 25450303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of salpingectomy on ovarian response to hyperstimulation during in vitro fertilization: a meta-analysis.
    Fan M; Ma L
    Fertil Steril; 2016 Aug; 106(2):322-329.e9. PubMed ID: 27114330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.